Page last updated: 2024-10-30

mesalamine and Liposclerotic Mesenteritis

mesalamine has been researched along with Liposclerotic Mesenteritis in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"She was diagnosed with Crohn's disease after undergoing colonoscopy and CT enterography."1.40[A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease]. ( Bae, GH; Kim, EJ; Kim, EY; Lee, HC; Lee, TS; Oh, HK; Song, JE, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, EJ1
Kim, EY1
Song, JE1
Lee, HC1
Bae, GH1
Oh, HK1
Lee, TS1

Other Studies

1 other study available for mesalamine and Liposclerotic Mesenteritis

ArticleYear
[A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Mar-25, Volume: 63, Issue:3

    Topics: Anti-Inflammatory Agents; Appendix; Azathioprine; Colonoscopy; Crohn Disease; Female; Humans; Immuno

2014